COMPANY

Renovare Therapeutics, Inc.

Renovare Therapeutics is a CU Boulder spinout developing regenerative therapies for osteoarthritis. Source · checked Oct 14, 2026

Keywords: osteoarthritis regenerative medicine drug delivery gene therapy biomaterials university spinout preclinical Boulder

Location: Boulder, CO · source · Oct 14, 2026

Profile checked Oct 14, 2026

Sourced facts

SEC Form D filed Oct 2, 2026: $100,000 sold of $1,000,000 offered · sec.gov · checked Oct 14, 2026

SEC Form D raise Raised $100K (Form D filed Oct 2, 2026). SEC Form D 0002158361-26-000001 (Oct 2, 2026)
Evidence (1 event)
- Oct 2, 2026 · SEC Form D 0002158361-26-000001
  Name of Issuer: Renovare Therapeutics, Inc.; CIK: 2158361; Address: Boulder, CO; Submission type: D; Filing date: 2026-10-02; Industry Group: Biotechnology; Date of First Sale: 2026-09-14; Types of Securities Offered: Option/warrant; Business combination transaction: false; Total Offering Amount: 1000000; Total Amount Sold: 100000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals